
Formycon and Bio Usawa Partner to Bring FYB201 (BioUcenta) to Sub-Saharan Africa
Formycon has announced a new strategic partnership involving Bioeq AG, the licensee and exclusive global commercialization rights holder for Formycon’s biosimilar FYB201, and the African biotechnology company Bio Usawa Biotechnology. This agreement grants …